Through a partnership with QHR Technologies, Inc. (TSX-V: QHR), Welch Allyn, a leading global provider of medical diagnostic solutions, now offers a more comprehensive line of connected vital signs devices in Canada’s primary care market. Welch Allyn vital signs devices now interface with one of Canada’s leading national electronic medical record (EMR) software solutions, Accuro®EMR—a comprehensive, physician clinic management program. The integration of Welch Allyn devices will allow electronic transfer of patient test results directly between the digital diagnostic devices and AccuroEMR—eliminating the need for manual data entry by providers, increasing efficiency and alleviating the risk of transcription and latency errors.
“By teaming with QHR, the largest Canadian EMR vendor, we are able to provide more EMR-ready devices to physician practices in Canada than any other medical device manufacturer in the world,” said John Tierney, SVP, Americas, Welch Allyn. “By offering more connected diagnostic testing options, we can help reduce some of the workflow pressures and safety issues these physicians are facing so they can be more productive and focus on their most important task—enhancing patient care.”
The agreement allows the Welch Allyn family of connected vital signs devices, including the Welch Allyn Connex® Vital Signs Monitor (Connex VSM) 6000 Series and Connex® ProBP™ 3400 Digital Blood Pressure Device, to integrate with the AccuroEMR solution that offers physician practices in Canada with robust capabilities for electronic health, practice management and claims management. It provides QHR access to the latest Welch Allyn vitals software developers kit (SDK) and enables broad marketing and sales collaboration between the two companies. Throughout the integration process, Welch Allyn provided QHR with remote technical guidance and support along with device testing and, most recently, installation support.
“Our alliance with Welch Allyn presents a unique opportunity for our two companies to create a streamlined diagnostic testing environment for our AccuroEMR clients,” said Al Hildebrandt, president and CEO, QHR Technologies, Inc. “Our technologies complement each other in ways that will directly enhance workflow for Canadian physicians. By sharing information and seamlessly integrating our technologies, we can achieve our shared vision to provide physicians with complete access to the right information at the right time. We are proud to partner with Welch Allyn and we look forward to the opportunities and benefits this creates for healthcare professionals and their patients across Canada.”
The Welch Allyn family of connected vital signs devices include:
- Vital Signs Monitor 300 Series
- Spot Vital Signs® Device
- Spot Vital Signs® LXi Device
- Connex® Vital Signs Monitor 6000 Series
- Connex® Integrated Wall System
- Connex® ProBP™ 3400 Digital Blood Pressure Device
The company’s full line of connected cardiopulmonary devices is currently being evaluated for release later this year, including:
- CP 100™ and CP 200™ Electrocardiographs (ECG)
- CardioPerfect® Workstation Software & Data Management System
- PC-Based Resting ECG
- PC-Based Exercise ECG
- PC-Based SpiroPerfect® Spirometer
- PC-Based Ambulatory Blood Pressure Monitor (ABPM)
Through a partnership with QHR Technologies, Inc. (TSX-V: QHR), Welch Allyn, a leading global provider of medical diagnostic solutions, now offers a more comprehensive line of connected vital signs devices in Canada’s primary care market.